Andy Tran

Biotech Investor, Matrix Capital Management, Board Director @ GentiBio arrow icon

About Andy Tran

Andy Tran is a biotech investor at Matrix Capital Management and serves as a board director.

Known information

Andy Tran holds a prominent position in the biotech industry as an investor with Matrix Capital Management. In addition to his role in investment, he contributes to strategic decision-making as a board director. His involvement in Matrix Capital Management allows him to play a significant role in shaping the future of biotechnology investments, leveraging his expertise to guide the company’s investment strategies and governance.

About GentiBio

GentiBio is a biotech company focused on developing engineered T regulatory cell therapies for various immune and inflammatory diseases, with its lead product GNTI-122 targeting type 1 diabetes.

report flag Report inaccurate information

People similar to Andy Tran

Jennifer Mellen

Principal Associate Scientist @ GentiBio

Jennifer Mellen is a Principal Associate Scientist.

Pramod Rompikuntal

Principal Scientist @ GentiBio

Pramod Rompikuntal is a Principal Scientist known for his contributions to his field.

David Tucker

Principal Scientist @ GentiBio

David Tucker is a Principal Scientist known for his significant contributions to his field.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free